• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rationale and design of a randomized study comparing Motivational Interviewing to Support Oral Anticoagulation adherence versus usual care in patients with nonvalvular atrial fibrillation: The MISOAC-AF trial.

作者信息

Samaras A, Kartas A, Vasdeki D, Dividis G, Forozidou E, Fotos G, Kotsi E, Paschou E, Tsoukra P, Goulas I, Karvounis H, Giannakoulas G, Tzikas A

机构信息

First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636, Thessaloniki, Greece.

First Department of Cardiology, AHEPA University Hospital, Aristotle University of Thessaloniki, St. Kiriakidi 1, 54636, Thessaloniki, Greece; Interbalkan European Medical Center, Asklipiou 10, Pylaia, Thessaloniki, Greece.

出版信息

Hellenic J Cardiol. 2020 Nov-Dec;61(6):453-454. doi: 10.1016/j.hjc.2020.02.007. Epub 2020 Apr 4.

DOI:10.1016/j.hjc.2020.02.007
PMID:32259588
Abstract
摘要

相似文献

1
Rationale and design of a randomized study comparing Motivational Interviewing to Support Oral Anticoagulation adherence versus usual care in patients with nonvalvular atrial fibrillation: The MISOAC-AF trial.一项随机研究的原理与设计：比较动机性访谈与常规护理对非瓣膜性心房颤动患者口服抗凝药物依从性的影响——MISOAC-AF试验
Hellenic J Cardiol. 2020 Nov-Dec;61(6):453-454. doi: 10.1016/j.hjc.2020.02.007. Epub 2020 Apr 4.
2
Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.直接口服抗凝剂与华法林在非瓣膜性心房颤动中的围手术期结局。
Circulation. 2018 Oct 2;138(14):1402-1411. doi: 10.1161/CIRCULATIONAHA.117.031457.
3
Motivational Interviewing to Support Oral AntiCoagulation adherence in patients with non-valvular Atrial Fibrillation (MISOAC-AF): a randomized clinical trial.动机性访谈对非瓣膜性心房颤动患者口服抗凝药物依从性的支持作用（MISOAC-AF）：一项随机临床试验。
Eur Heart J Cardiovasc Pharmacother. 2021 Apr 9;7(FI1):f63-f71. doi: 10.1093/ehjcvp/pvaa039.
4
Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.直接口服抗凝剂与维生素K拮抗剂在非瓣膜性心房颤动中的疗效和安全性比较：一项加拿大多中心观察性队列研究。
CMAJ Open. 2020 Dec 18;8(4):E877-E886. doi: 10.9778/cmajo.20200055. Print 2020 Oct-Dec.
5
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.新型口服抗凝药物在房颤卒中预防中的应用：重点关注阿哌沙班。
Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7.
6
Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials.非维生素K拮抗剂口服抗凝药与华法林在糖尿病房颤患者中的安全性和有效性：一项III期随机试验的研究水平荟萃分析
Diabetes Metab Res Rev. 2017 Mar;33(3). doi: 10.1002/dmrr.2876. Epub 2017 Jan 27.
7
Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale: From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.来自 COMBINE AF（多个机构之间的合作，以更好地研究非维生素 K 拮抗剂口服抗凝剂在心房颤动中的应用）研究人员的非维生素 K 拮抗剂口服抗凝剂在心房颤动患者中的关键性随机对照试验的个体患者数据（COMBINE AF）：设计和原理。
Am Heart J. 2021 Mar;233:48-58. doi: 10.1016/j.ahj.2020.12.002. Epub 2020 Dec 6.
8
Eligibility and preference of new oral anticoagulants in patients with atrial fibrillation: comparison between patients with versus without stroke.心房颤动患者使用新型口服抗凝剂的适用性和偏好：有卒中与无卒中患者的比较
Stroke. 2014 Oct;45(10):2983-8. doi: 10.1161/STROKEAHA.114.005599. Epub 2014 Aug 21.
9
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.心房颤动卒中后抗凝治疗的三个月风险效益概况：SAMURAI-非瓣膜性心房颤动（NVAF）研究
Int J Stroke. 2016 Jul;11(5):565-74. doi: 10.1177/1747493016632239. Epub 2016 Feb 29.
10
Indirect Comparison of Novel Oral Anticoagulants in Women with Nonvalvular Atrial Fibrillation.新型口服抗凝剂在非瓣膜性心房颤动女性患者中的间接比较
J Womens Health (Larchmt). 2017 Mar;26(3):214-221. doi: 10.1089/jwh.2016.5892. Epub 2016 Nov 21.

引用本文的文献

1
Oral Anticoagulation Choice and Dosage in Very Elderly Patients with Atrial Fibrillation.高龄房颤患者的口服抗凝治疗选择与剂量
J Cardiovasc Dev Dis. 2025 Feb 26;12(3):86. doi: 10.3390/jcdd12030086.
2
Predictors and prognosis of elderly hip fracture patients with perioperative atrial fibrillation: a nested case-control study.老年髋部骨折患者围手术期心房颤动的预测因素及预后：一项巢式病例对照研究。
BMC Geriatr. 2025 Jan 3;25(1):4. doi: 10.1186/s12877-024-05647-1.
3
Prognostic Impact of Body Mass Index in Atrial Fibrillation.体重指数对心房颤动的预后影响
J Clin Med. 2024 Jun 3;13(11):3294. doi: 10.3390/jcm13113294.
4
Prognostic implications of thyroid disease in patients with atrial fibrillation.甲状腺疾病对心房颤动患者预后的影响。
Heart Vessels. 2024 Feb;39(2):185-193. doi: 10.1007/s00380-023-02341-x. Epub 2023 Dec 13.
5
Changes in CHADS-VASc score and risk of ischemic stroke among patients with atrial fibrillation.房颤患者 CHADS-VASc 评分变化与缺血性脑卒中风险
Heart Vessels. 2023 Oct;38(10):1267-1276. doi: 10.1007/s00380-023-02278-1. Epub 2023 Jun 13.
6
Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease.心房颤动合并慢性阻塞性肺疾病患者使用心脏选择性与非心脏选择性β受体阻滞剂的疗效比较
J Clin Med. 2023 Apr 23;12(9):3063. doi: 10.3390/jcm12093063.
7
Sex-Related Differences in Clinical Outcomes in Patients with Atrial Fibrillation and Coronary Artery Disease: A Sub-Study of the MISOAC-AF Randomized Controlled Trial.心房颤动合并冠状动脉疾病患者临床结局的性别差异：MISOAC-AF随机对照试验的一项子研究
J Clin Med. 2022 Oct 1;11(19):5843. doi: 10.3390/jcm11195843.
8
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation.非瓣膜性心房颤动患者瓣膜性心脏病的预后意义。
BMC Cardiovasc Disord. 2021 Sep 18;21(1):453. doi: 10.1186/s12872-021-02264-3.
9
Τhe association of heart failure across left ventricular ejection fraction with mortality in atrial fibrillation.心力衰竭与射血分数左心室在心房颤动患者死亡率的关系。
ESC Heart Fail. 2021 Aug;8(4):3189-3197. doi: 10.1002/ehf2.13440. Epub 2021 Jun 3.
10
Prognostic significance of diabetes mellitus in patients with atrial fibrillation.糖尿病与心房颤动患者的预后意义。
Cardiovasc Diabetol. 2021 Feb 11;20(1):40. doi: 10.1186/s12933-021-01232-7.